$LQDA
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Healthcare
Sector
Biotechnology
Industry
Roger A. Jeffs
CEO
170
Employees
$62.03
Current Price
$3.40B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $399,712.32 | 6,428 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 6 | $8,281,370.70 | 135,922 | ||
| 1 month | Buys | 1 | 1 | $317,894.00 | 5,300 | 1:120.53 |
| Sells | 4 | 24 | $38,316,524.70 | 735,115 | ||
| 2 months | Buys | 1 | 1 | $317,894.00 | 5,300 | 1:186.06 |
| Sells | 11 | 47 | $59,148,698.87 | 1,258,071 | ||
| 3 months | Buys | 1 | 1 | $317,894.00 | 5,300 | 1:213.29 |
| Sells | 11 | 57 | $67,804,621.18 | 1,498,245 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 27, 2026 | JEFFS ROGER Director | Sale | 6,428 | $62.18 | $399,712.32 | View Details |
| May 21, 2026 | SINGH RAMAN Director | Sale | 29,494 | $60.13 | $1,773,435.88 | View Details |
| May 21, 2026 | JEFFS ROGER Director | Sale | 25,000 | $61.13 | $1,528,160.00 | View Details |
| May 22, 2026 | JEFFS ROGER Director | Sale | 25,000 | $61.52 | $1,538,055.00 | View Details |
| May 26, 2026 | JEFFS ROGER Director | Sale | 25,000 | $60.38 | $1,509,460.00 | View Details |
| May 19, 2026 | Caligan Partners LP Director | Purchase | 5,300 | $59.98 | $317,894.00 | View Details |
| May 19, 2026 | Caligan Partners LP Director | Sale | 5,300 | $59.98 | $317,894.00 | View Details |
| May 18, 2026 | JEFFS ROGER Director | Sale | 25,000 | $56.77 | $1,419,320.00 | View Details |
| May 20, 2026 | JEFFS ROGER Director | Sale | 25,000 | $61.30 | $1,532,547.50 | View Details |
| May 19, 2026 | JEFFS ROGER Director | Sale | 25,000 | $58.65 | $1,466,142.50 | View Details |
| May 13, 2026 | JEFFS ROGER Director | Sale | 25,000 | $56.29 | $1,407,127.50 | View Details |
| May 15, 2026 | JEFFS ROGER Director | Sale | 25,000 | $57.04 | $1,426,072.50 | View Details |
| May 14, 2026 | JEFFS ROGER Director | Sale | 25,000 | $58.62 | $1,465,565.00 | View Details |
| May 11, 2026 | Bloch Stephen M Director | Sale | 27,613 | $50.10 | $1,383,491.38 | View Details |
| May 11, 2026 | Bloch Stephen M Director | Sale | 10,500 | $51.31 | $538,762.35 | View Details |
| May 11, 2026 | Bloch Stephen M Director | Sale | 75,801 | $48.61 | $3,684,535.01 | View Details |
| May 11, 2026 | Bloch Stephen M Director | Sale | 14,207 | $53.25 | $756,565.37 | View Details |
| May 11, 2026 | Bloch Stephen M Director | Sale | 115,479 | $49.45 | $5,709,882.25 | View Details |
| May 11, 2026 | Bloch Stephen M Director | Sale | 75,293 | $52.38 | $3,943,538.64 | View Details |
| May 12, 2026 | JEFFS ROGER Director | Sale | 25,000 | $54.04 | $1,350,990.00 | View Details |
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated$0.01
ActualN/A
Revenue
EstimatedN/A
ActualN/A